跳至主要内容
临床试验/NL-OMON27317
NL-OMON27317招募中不适用

Assessment of the prognostic value of MM related bone disease as detected by Whole Body X Ray (WBXR), Whole Body - Magnetic Resonance Imaging (WB-MRI) and FluoroDeoxyGlucose - Positron Emission Tomography - Computer Tomography (FDG-PET-CT) at diagnosis (part I) and in follow-up (part II).

HOVO0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
60

研究概览

简要总结

/A

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Inclusion in the HOVON 87 study;
  • 2. To be included in part II, patients have to participate in part I of the study.

排除标准

  • 1. Contraindications for MRI (including e.g. pacemaker, ICD, metallic splinter in eye, hemostatic clips in CNS, claustrofobia, or other implants that are contraindicated according to the MRI operator’s discretion);
  • 2. Physical inability to access either MRI or PET-CT facilities;

研究者

发起方
HOVO

相似试验